Clene Inc. Clene Inc.
  • About Us
    • Leadership
    • Board of Directors
  • Science
    • About CNM-Au8®
  • Pipeline
  • Patients
    • EAP
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • News
      • Events
    • Presentations
      • Investor Presentation
      • Scientific Posters & Presentations
      • Webinars
      • Publications
    • Corporate Governance
      • Executive Management
      • Board of Directors
      • Committee Composition
      • Governance Documents
    • Financial Information
      • SEC Filings
      • Annual Reports
    • Stock
      Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Investor Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
  • Contact
Clene Inc. Clene Inc.
  • About Us
    • Leadership
    • Board of Directors
  • Science
    • About CNM-Au8®
  • Pipeline
  • Patients
    • EAP
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • News
      • Events
    • Presentations
      • Investor Presentation
      • Scientific Posters & Presentations
      • Webinars
      • Publications
    • Corporate Governance
      • Executive Management
      • Board of Directors
      • Committee Composition
      • Governance Documents
    • Financial Information
      • SEC Filings
      • Annual Reports
    • Stock
      Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Analyst Coverage
    • Investor Resources
      • Investor FAQs
      • Information Request Form
      • Investor Email Alerts
  • Contact

Reed N Wilcox

Reed Wilcox is the President of Southern Virginia University. Reed co-founded Clene Nanomedicine. Prior to Clene Nanomedicine, President Wilcox was co-founder and senior managing director of General Resonance. Earlier, Reed... read more →
  • November 2, 2021
  • Adam Dorfman

Jonathon Gay

Mr. Gay is a Managing Partner at Kensington-SV Global Innovations LP (KSV), a growth stage investment firm which he co-founded in 2018. Prior to joining KSV, Mr. Gay was Managing... read more →
  • November 2, 2021
  • Adam Dorfman

Vallerie V. McLaughlin, MD

Vallerie V. McLaughlin, MD, is the Kim A. Eagle MD Endowed Professor of Cardiovascular Medicine, and Director of the Pulmonary Hypertension Program at the University of Michigan in Ann Arbor.... read more →
  • November 2, 2021
  • Adam Dorfman

John Stevens, MD

John Stevens, MD, currently serves as the chairman and CEO of Heartflow, Inc, a provider of noninvasive cardiovascular imaging technology, and as the managing partner of Headwaters Capital Partners. John... read more →
  • November 2, 2021
  • Adam Dorfman

Shalom “Shal” Jacobovitz

Shalom “Shal” Jacobovitz is the chief executive officer of CIVI Bio, a privately held biopharmaceutical, and the former CEO of the American College of Cardiology. In this role at the... read more →
  • November 2, 2021
  • Adam Dorfman

Chidozie Ugwumba

Chidozie Ugwumba serves as Managing Partner of SymBiosis, a venture capital firm focused on investments in biotherapeutics. At SymBiosis, Mr. Ugwumba leads sourcing, due diligence, and execution of investments, and... read more →
  • November 2, 2021
  • Adam Dorfman

Alison Mosca

Alison Mosca is a Managing Director & CEO of Kensington Capital Holdings. Prior to founding Kensington Capital Holdings, Alison built a multi-family office within Audax Group, a leading middle market... read more →
  • November 2, 2021
  • Adam Dorfman

Rob Etherington

Mr. Etherington brings nearly 30 years of sales, marketing and leadership experience in the pharmaceutical industry to Clene. Prior to joining Clene as CEO, Mr. Etherington worked for Actelion Pharmaceuticals,... read more →
  • November 2, 2021
  • Adam Dorfman

David J. Matlin

Mr. Matlin was the Chief Executive Office of MatlinPatterson Global Advisers LLC, a global private equity firm, which he co-founded in 2002. David was a former Managing Director at Credit... read more →
  • November 2, 2021
  • Adam Dorfman



1-801-676-9695
info@CleneNanomedicine.com
@CleneNano

Headquarters and Development

6550 South Millrock Drive, Suite G50
Salt Lake City, Utah 84121

Manufacturing, R&D

500 Principio Parkway West Suite 400
North East, Maryland 21901

Clene Nanomedicine, Inc. is a wholly owned subsidiary of Clene Inc. | © 2022 Clene Nanomedicine, Inc. - All rights reserved